Incidence, epidemiology and treatment results of osteosarcoma in Finland - A nationwide population-based study

Acta Oncologica

Volumn 50, Issue 8, 2011, Pages 1206-1214

  Sampo, Mika ^a,b   Koivikko, Mika ^b   Taskinen, Mervi ^b   Kallio, Pentti ^b   Kivioja, Aarne ^b   Tarkkanen, Maija ^b   Böhling, Tom ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC VALUE; DISEASE MARKER; EVALUATION AND FOLLOW UP; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; BONE NEOPLASMS; FEMALE; FINLAND; HUMANS; INCIDENCE; MALE; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 80155195079     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.615339     Document Type: Article

References (21)

1. Fletcher CDM, Unri KK, Mertens F. WHO classifi cation of tumors pathology and genetics tumors of soft tissue and bone. 1st ed. Lyon: IARC Press; 2002.
2. Huvos AG. In: Bone tumors. Diagnosis, treatment and prognosis. 2 nd ed. Philadelphia: W.B. Saunders; 1991
3. Smeland S, Muller C, Alvegard TA, Wiklund T, Wiebe T, Bjork O, et al. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: Prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003;39:488-94.
4. Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, et al. Neoadjuvant chemotherapy with highdose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005;23:8845-52.
5. Harvei S, Solheim O. The prognosis in osteosarcoma: Norwegian National Data. Cancer 1981;48:1719-23.
6. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
7. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980;153:106-20.
8. Fagioli F, Aglietta M, Tienghi A, Ferrari S, Brach del Prever A, Vassallo E, et al. High-dose chemotherapy in the treatment of relapsed osteosarcoma: An Italian sarcoma group study. J Clin Oncol 2002;20:2150-6.
9. Brach Del Prever A, Smeland S, Tienghi A, Hall KS, Aglietta M, Bernini G, et al. High-risk osteosarcoma (OS): Preliminary results of the ISG-SSG II protocol. J Clin Oncol, 2005 ASCO Annual Meeting Proceedings. 2005; 23:9002.
10. Smeland S, Bruland OS, Hjorth L, Brosjo O, Bjerkehagen B, Osterlundh G, et al. Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma. Acta Orthop 2011;82:211-6.
11. Larsson SE, Lorentzon R. The incidence of malignant primary bone tumours in relation to age, sex and site. A study of osteogenic sarcoma, chondrosarcoma and Ewing's sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Joint Surg Br 1974;56B:534-40.
12. Curry H, Horne G, Devane P, Tobin H. Osteosarcoma in New Zealand: An outcome study comparing survival rates between 1981 - 1987 and 1994 - 1999. N Z Med J 2006;119: U2234.
13. Stiller CA, Passmore SJ, Kroll ME, Brownbill PA, Wallis JC, Craft AW. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980 - 1994. Br J Cancer 2006;94:22-9.
14. Sampo MM, Tarkkanen M, Kivioja AH, Taskinen MH, Sankila R, Bohling TO. Osteosarcoma in Finland from 1971 through 1990: A nationwide study of epidemiology and outcome. Acta Orthop 2008;79:861-6.
15. Picci P, Mercuri M, Ferrari S, Alberghini M, Briccoli A, Ferrari C, et al. Survival in high-grade osteosarcoma: Improvement over 21 years at a single institution. Ann Oncol 2010;21:1366-73.
16. Eyre R, Feltbower RG, James PW, Blakey K, Mubwandarikwa E, Forman D, et al. The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002. BMC Cancer 2010;10:357.
17. Briccoli A, Rocca M, Salone M, Guzzardella GA, Balladelli A, Bacci G. High grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985 - 2005. Surg Oncol 2010;19:193-9.
18. Ward WG, Mikaelian K, Dorey F, Mirra JM, Sassoon A, Holmes EC, et al. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994;12:1849-58.
19. Ferrari S, Bacci G, Picci P, Mercuri M, Briccoli A, Pinto D, et al. Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol 1997;8: 765-71.
20. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 1992;10:5-15.
21. Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PC, et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensify ed chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007;99:112-28.